Skip to main content.

Darlene Donloe's Blog

"I wanted to give the Black community in Los Angeles all the information they would need to be... more »
posted 10/21/21
Why is the silent epidemic of Alzheimer's more prevalent among Blacks than among whites and other... more »
posted 04/08/21

Darlene Donloe's Work

The fourth and last in a series of articles on the impact of Alzheimer’s disease on the Black community in Los Angeles.
Aducanumab is the first new drug approved to treat Alzheimer’s disease in nearly 20 years. But some in the medical community were stunned by the approval.
“We are still trying to understand how it manifests and how it happens,” said Dr. Emnet Gammada, a clinical geriatric neuro-psychology fellow at the UCLA Semel Institute of Neuroscience and Human Behavior. “What surprises me is how much we know and how much we don’t know.”